Advancing neurodegenerative disease research into the clinic

Prof. Craig Ritchie will explore the rapid growth of his life sciences startup, Scottish Brain Sciences, and discuss the journey of commercialisation within the brain health sector.

Neurodegenerative diseases represent one of the world’s most pressing health challenges. Globally, the numbers of people living with dementia will increase from 55 million in 2020 to 79 million in 2030 and 139 million in 2050.

ONE Life Sciences Network will be joined by Prof Craig Ritchie, founder and CEO of Scottish Brain Sciences, Honorary Chair of the Psychiatry of Ageing at the University of Edinburgh and Founder of Brain Health Scotland. Prof. Ritchie will explore the rapid growth of his life sciences startup, Scottish Brain Sciences, and discuss the journey of commercialisation within the brain health sector.

Founded in 2022, Scottish Brain Sciences is accelerating the development and implementation of new diagnostics and therapeutics for Alzheimer’s disease and other related conditions. Operating from its clinical trials centre at ONE BioHub, which includes state-of-the-art offices, laboratories, and consulting rooms, the team collaborates with local universities, the NHS, and the broader life sciences community to recruit participants for its groundbreaking IONA longitudinal cohort study. IONA is recruiting ten times faster than any other study of its kind to create one of the world’s largest brain health research communities, transforming research into Alzheimer’s disease.

During the event Prof. Ritchie will discuss his recent move to ONE BioHub, his aspirations and strategic plans for the future of brain health research in northeast Scotland, and the opportunities available for businesses, researchers, and healthcare professionals in the region.

This event will be valuable for early-stage (pre-)spinouts, established life sciences companies, academics, NHS professionals, and service providers interested in the commercialisation of medical research, diagnostics, and therapeutics.

Participants will gain:

• Exclusive Insights: Gain first-hand knowledge of best practices in developing and commercialising a diagnostics company within the brain health sector
• Collaboration Strategies: Learn how Scottish Brain Sciences successfully collaborates with pharmaceutical companies and commercial partners to bring innovative solutions to market
• Patient Recruitment & Engagement: Discover effective approaches for recruiting patients and engaging with patient groups, which are critical to the success of clinical trials and research initiatives

Dr Deborah O’Neil OBE, chair of the ONE life sciences board and ONE BioHub will provide a ONE Life Sciences update to finish.

The ONE Life Sciences Network brings together people from the academic, clinical, commercial and research community to focus on collaborative innovation and commercialisation. Its quarterly meetings deliver high-quality insights into sector growth, emerging trends, and market-related topics that are shaping the future of life sciences.

Please register via the link below to attend this free event. If you have any questions, please contact info@onebiohub.com.